EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Prevalence of hypertension-mediated target organ damage in hypertensive patients in an outpatient setting – An observational study

Ajay Jaryal, Bhupender Kumar, Nripen Gaur, Kapil Sharma, Sanjay Vikrant, Nitin Kumar

International Journal of Noncommunicable Diseases · 2025-01 · 10 (1) · 12-16

DOI: 10.4103/jncd.jncd_51_24 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Aim: We aimed to study the clinical profile of hypertensive patients in an outpatient setting and to assess the burden and pattern of hypertension-mediated target organ damage (HMOD). Materials and Methods: A prospective observational study evaluated the clinical profile of hypertensive patients who attended a general internal medicine outpatient clinic over 1 year from April 2022 to March 2023. Results: A total of 454 patients (64.5% – preexisting hypertension, 35.5% – newly diagnosed) were found hypertensive during outpatient visits during the study period. About 22.7% had symptoms at the time of diagnosis of hypertension, and the leading symptoms were dizziness, headache, angina, and pregnancy-induced hypertension. Twenty-one percent had isolated systolic hypertension. Of the patient with preexisting hypertension, 26.28% had their hypertension under control. Among the patients taking antihypertensive drugs 49% were on single antihypertensive drug, 43% on two antihypertensive drugs, and 8% on ≥3 drugs. The most commonly used antihypertensive drugs were amlodipine and telmisartan. The prevalence of hypertension-mediated organ damage was seen in 20% with isolated systolic hypertension, 30.76% with preexisting hypertension, and 33.3% with newly diagnosed hypertension. Electrocardiographic left ventricular hypertrophy was leading hypertension-mediated organ damage followed by hypertensive retinopathy and proteinuria. Overall, hypertension-mediated organ damage was less common in patients with isolated systolic hypertension ( P = 0.008). Conclusion: Only around one-fourth of hypertensive patients have their hypertension under control. HMOD is prevalent in around one-third of newly diagnosed hypertensive patients.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →